De Gracia, Rixnel B.
HRN: 22-07-19 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/17/2022
10/24/2022
ORAL
12 Ml
8 Hrs
Intestinal Amebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes